| 000 | 01891 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516015509.0 | ||
| 264 | 0 | _c20120917 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1473-1150 | ||
| 024 | 7 |
_a10.1038/tpj.2010.91 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMas, S | |
| 245 | 0 | 0 |
_aIntuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes. _h[electronic resource] |
| 260 |
_bThe pharmacogenomics journal _cJun 2012 |
||
| 300 |
_a255-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xgenetics |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
| 650 | 0 | 4 | _aDrug Dosage Calculations |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntuition |
| 650 | 0 | 4 | _aLinkage Disequilibrium |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRisperidone _xadministration & dosage |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 |
_aSpain _xepidemiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWhite People _xgenetics |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGassò, P | |
| 700 | 1 | _aAlvarez, S | |
| 700 | 1 | _aParellada, E | |
| 700 | 1 | _aBernardo, M | |
| 700 | 1 | _aLafuente, A | |
| 773 | 0 |
_tThe pharmacogenomics journal _gvol. 12 _gno. 3 _gp. 255-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/tpj.2010.91 _zAvailable from publisher's website |
| 999 |
_c20462010 _d20462010 |
||